Pulmatrix PULM
NASDAQ PULM
$1.54 +0.01 (+0.65%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pulmatrix (PULM) Liabilities and Shareholders Equity (2014 - 2026)

Updated

Pulmatrix (PULM) posted Liabilities and Shareholders Equity of $3.25 million for Q2 2026, down 47.2% from $6.15 million a year earlier and down 27.8% from the prior quarter.

Analysis

Pulmatrix (PULM) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

At the end of FY2025, Pulmatrix's Liabilities and Shareholders Equity came in at $4.14 million, down 58.4% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -35.8% (FY2020 to FY2025).
  • In prior years, Pulmatrix's Liabilities and Shareholders Equity was $9.94 million in FY2024 (-70.7%), $33.96 million in FY2023 (-17.1%), $40.95 million in FY2022 (-30.4%) and $58.82 million in FY2021 (+54.4%).
  • The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q4 2014.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 18 quarters, with an average decline of 60.1% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2021, with growth of 54.4%; the weakest was Q1 2025, with a decline of 73.5%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $4.5 million (Q1 2026), $4.14 million (Q4 2025) and $4.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Pulmatrix 5.55 Mn 5.55 Mn - 3.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.25 Mn
Mar 31, 2026 4.50 Mn
Dec 31, 2025 4.14 Mn
Sep 30, 2025 4.98 Mn
Jun 30, 2025 6.15 Mn
Mar 31, 2025 8.05 Mn
Dec 31, 2024 9.94 Mn
Sep 30, 2024 11.51 Mn
Jun 30, 2024 15.78 Mn
Mar 31, 2024 30.39 Mn
Dec 31, 2023 33.96 Mn
Sep 30, 2023 36.77 Mn
Jun 30, 2023 31.39 Mn
Mar 31, 2023 36.06 Mn
Dec 31, 2022 40.95 Mn
Sep 30, 2022 46.45 Mn
Jun 30, 2022 49.40 Mn
Mar 31, 2022 54.30 Mn
Dec 31, 2021 58.82 Mn
Sep 30, 2021 55.75 Mn
API Access

Pulmatrix Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PULM&period=max&api_key=YOUR_API_KEY